These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7590419)

  • 21. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
    Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF
    Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of clinical remission in recent-onset IDDM.
    Hramiak IM; Dupre J; Finegood DT
    Diabetes Care; 1993 Jan; 16(1):125-32. PubMed ID: 8422766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults.
    Schölin A; Nyström L; Arnqvist H; Bolinder J; Björk E; Berne C; Karlsson FA;
    Diabet Med; 2011 Feb; 28(2):156-61. PubMed ID: 21219422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase.
    Schober E; Schernthaner G; Frisch H; Fink M
    J Endocrinol Invest; 1984 Oct; 7(5):507-12. PubMed ID: 6392401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group.
    Pozzilli P; Visalli N; Boccuni ML; Baroni MG; Buzzetti R; Fioriti E; Signore A; Cavallo MG; Andreani D; Lucentini L
    Diabet Med; 1994; 11(1):98-104. PubMed ID: 8181261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
    Diabetes; 1988 Nov; 37(11):1574-82. PubMed ID: 2903105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.
    Assan R; Feutren G; Debray-Sachs M; Quiniou-Debrie MC; Laborie C; Thomas G; Chatenoud L; Bach JF
    Lancet; 1985 Jan; 1(8420):67-71. PubMed ID: 2857024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis.
    D'Addio F; Valderrama Vasquez A; Ben Nasr M; Franek E; Zhu D; Li L; Ning G; Snarski E; Fiorina P
    Diabetes; 2014 Sep; 63(9):3041-6. PubMed ID: 24947362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.
    Koivisto VA; Aro A; Cantell K; Haataja M; Huttunen J; Karonen SL; Mustajoki P; Pelkonen R; Seppälä P
    Diabetologia; 1984 Aug; 27(2):193-7. PubMed ID: 6386581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IA-2 antibody-negative status predicts remission and recovery of C-peptide levels in type 1 diabetic patients treated with cyclosporin.
    Christie MR; Mølvig J; Hawkes CJ; Carstensen B; Mandrup-Poulsen T;
    Diabetes Care; 2002 Jul; 25(7):1192-7. PubMed ID: 12087018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of early cyclosporin therapy in juvenile IDDM.
    De Filippo G; Carel JC; Boitard C; Bougnères PF
    Diabetes; 1996 Jan; 45(1):101-4. PubMed ID: 8522052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin A treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus. London Diabetes Study Group.
    Jenner M; Bradish G; Stiller C; Atkison P
    Diabetologia; 1992 Sep; 35(9):884-8. PubMed ID: 1397785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.
    Ludvigsson J; Heding LG; Larsson Y; Leander E
    Acta Paediatr Scand; 1977 Mar; 66(2):177-84. PubMed ID: 402787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of insulin reserves in the first 18 months in the insulin-dependent diabetic with or without remission of insulin-dependence].
    Brucker F; Boda-Buccino M; Bellet C; Fredenrich A; Fenichel P; Claude MH; Hieronimus S; Harter M
    Presse Med; 1988 Dec; 17(44):2340-3. PubMed ID: 2974970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remission Phase in Paediatric Type 1 Diabetes: New Understanding and Emerging Biomarkers.
    Fonolleda M; Murillo M; Vázquez F; Bel J; Vives-Pi M
    Horm Res Paediatr; 2017; 88(5):307-315. PubMed ID: 28772271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin: beneficial effects on remission in young adult patients with newly diagnosed diabetes mellitus type 1.
    Vondra K; Voborská M; Kvapil M; Weber P; Dvoráková H; Stanická S; Zamrazil V
    Physiol Res; 2004; 53(1):115-7. PubMed ID: 14984323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-peptide response to arginine stimulation in diabetic children.
    Menchini M; Meschi F; Lambiase R; Puzzovio M; Del Guercio MJ; Chiumello G
    J Pediatr; 1980 Mar; 96(3 Pt 1):362-6. PubMed ID: 6987353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
    Feutren G; Papoz L; Assan R; Vialettes B; Karsenty G; Vexiau P; Du Rostu H; Rodier M; Sirmai J; Lallemand A
    Lancet; 1986 Jul; 2(8499):119-24. PubMed ID: 2873396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Remission induced at the early stage of insulin-dependent diabetes: do predictive factors exist?].
    Sudre Y; Marechaud R; Rossi F; Abadie JC; Gouet D
    Rev Med Interne; 1984 Sep; 5(3):206-11. PubMed ID: 6390593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.
    Mirouze J; Selam JL; Pham TC; Mendoza E; Orsetti A
    Diabetologia; 1978 Apr; 14(4):223-7. PubMed ID: 640299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.